The United States House Appropriations Committee has voted to approve legislation that would direct the Drug Enforcement Administration (DEA) to determine a plan for accelerating the approval process for those wanting to study cannabis.
Specifically, the provision – which is attached to a federal spending bill – mandates the agency to “review all relevant DEA rules governing research on the medical efficacy of marijuana and determine ways to facilitate further research through streamlining the DEA approval process.”
